18 November 2022
- 17:3117:31, 18 November 2022 diff hist +944 User talk:SighSci →Block modified due to ongoing disruption: Reply Tag: Reply
22 September 2022
- 18:0718:07, 22 September 2022 diff hist +2,360 Talk:Simufilam →Allegations of research irregularities section: Reply Tag: Reply
20 September 2022
- 20:4220:42, 20 September 2022 diff hist +373 Talk:Simufilam →Allegations of research irregularities section: Reply Tag: Reply
- 19:1419:14, 20 September 2022 diff hist +878 Talk:Simufilam →Allegations of research irregularities section: Reply Tag: Reply
- 19:0419:04, 20 September 2022 diff hist +1,544 Talk:Simufilam →Allegations of research irregularities section: Reply Tag: Reply
12 September 2022
- 18:4818:48, 12 September 2022 diff hist +728 Talk:Simufilam →Allegations of research irregularities section: new section Tag: New topic
- 18:4218:42, 12 September 2022 diff hist +1,006 Talk:Simufilam →Mechanism: Reply Tag: Reply
- 17:5317:53, 12 September 2022 diff hist +863 Talk:Cassava Sciences →Biomarkers, outside lab: Reply Tag: Reply
10 September 2022
- 21:2621:26, 10 September 2022 diff hist +282 Talk:Cassava Sciences →Table of primary sources: Reply Tag: Reply
5 September 2022
- 23:1223:12, 5 September 2022 diff hist +201 Talk:Cassava Sciences →No products approved by the FDA: Reply Tag: Reply
- 17:4417:44, 5 September 2022 diff hist +548 Talk:Cassava Sciences →No products approved by the FDA: Reply Tag: Reply
- 17:3917:39, 5 September 2022 diff hist +431 Talk:Cassava Sciences →"Chemical signals" quote: Reply Tag: Reply
- 16:5716:57, 5 September 2022 diff hist +565 Talk:Cassava Sciences →Edits needed to keep this page neutral: Reply Tag: Reply
- 16:4816:48, 5 September 2022 diff hist +481 Talk:Cassava Sciences →No products approved by the FDA: Reply Tag: Reply
2 September 2022
- 18:4818:48, 2 September 2022 diff hist +719 Talk:Cassava Sciences →"Chemical signals" quote: Reply Tag: Reply
- 15:3615:36, 2 September 2022 diff hist +730 Talk:Cassava Sciences →Table of primary sources: Reply Tag: Reply
1 September 2022
- 17:5217:52, 1 September 2022 diff hist +167 User talk:SighSci →Block notice: Reply Tag: Reply
31 August 2022
- 22:5422:54, 31 August 2022 diff hist +960 Talk:Cassava Sciences/Primary sources →Discussion, comments and queries: Reply Tag: Reply
- 21:2321:23, 31 August 2022 diff hist +648 User talk:SighSci →August 2022: Reply Tag: Reply
- 17:5717:57, 31 August 2022 diff hist +965 User talk:SighSci →August 2022: Reply Tag: Reply
- 15:0215:02, 31 August 2022 diff hist +362 User talk:SighSci →August 2022: Reply Tag: Reply
30 August 2022
- 23:1723:17, 30 August 2022 diff hist +937 Wikipedia:Conflict of interest/Noticeboard →Simufilam: Reply Tag: Reply
- 20:2920:29, 30 August 2022 diff hist +1,074 User talk:SighSci →August 2022: Reply Tag: Reply
- 19:5419:54, 30 August 2022 diff hist +289 Talk:Cassava Sciences →Leadership: Reply Tag: Reply
- 02:1602:16, 30 August 2022 diff hist +579 Simufilam Added reaction from third journal publishing simufilam paper Tag: Reverted
- 01:5401:54, 30 August 2022 diff hist +613 Talk:Lindsay Burns →Intro suggestions: new section Tag: New topic
29 August 2022
- 18:2718:27, 29 August 2022 diff hist +892 Talk:Cassava Sciences →Allegations of research fraud: Reply Tag: Reply
- 18:1018:10, 29 August 2022 diff hist +225 Talk:Cassava Sciences →Allegations of research fraud: Reply Tag: Reply
- 17:1517:15, 29 August 2022 diff hist +558 Talk:Cassava Sciences →Allegations of research fraud.: new section Tag: New topic
27 August 2022
- 16:3316:33, 27 August 2022 diff hist +623 User talk:SighSci →Do you have a conflict of interest?: Reply Tag: Reply
26 August 2022
- 16:3516:35, 26 August 2022 diff hist +1,005 Talk:Cassava Sciences/Primary sources →Primary source journal papers: added 2005 Neuroscience paper Tag: Reverted
- 01:0701:07, 26 August 2022 diff hist +3,034 User talk:SighSci →Do you have a conflict of interest?: Reply Tag: Reply
25 August 2022
- 19:2719:27, 25 August 2022 diff hist −6 Cassava Sciences removed "after" that misleadingly implied a sequence Tag: Reverted
- 16:2816:28, 25 August 2022 diff hist +715 Talk:Cassava Sciences →Intro needs help: Reply Tag: Reply
24 August 2022
- 20:4220:42, 24 August 2022 diff hist +1,457 Talk:Cassava Sciences/Primary sources added comments, added third simufilam publication
- 18:1418:14, 24 August 2022 diff hist +596 User talk:SighSci →Your edits on Cassava Sciences-related articles and my time: Reply Tag: Reply
- 18:0718:07, 24 August 2022 diff hist +224 Cassava Sciences →Products: Added publications of Remoxy
- 14:4314:43, 24 August 2022 diff hist +1,073 Simufilam →Reactions from the journals: updated to include the third simufilam paper Tag: Reverted
- 13:2313:23, 24 August 2022 diff hist +851 Talk:Cassava Sciences →Neuroscience article: Reply Tag: Reply
- 13:1613:16, 24 August 2022 diff hist +342 Talk:Cassava Sciences →Cleanup: Reply Tag: Reply
23 August 2022
- 02:0602:06, 23 August 2022 diff hist +937 Talk:Cassava Sciences →IIb to III: Reply Tag: Reply
22 August 2022
- 21:2021:20, 22 August 2022 diff hist +1,746 Talk:Cassava Sciences →Compliance week article research should be added: Reply Tag: Reply
- 14:4914:49, 22 August 2022 diff hist +1,919 Talk:Cassava Sciences →Compliance week article research should be added: Reply Tag: Reply
- 01:4601:46, 22 August 2022 diff hist +282 Talk:Cassava Sciences →Planned enrollment in Phase 3 trials: Reply Tag: Reply
21 August 2022
- 18:2118:21, 21 August 2022 diff hist +1,892 Talk:Cassava Sciences →Compliance week article research should be added: Reply Tag: Reply
- 16:1916:19, 21 August 2022 diff hist +1,728 Talk:Cassava Sciences →SavaDx: Reply Tag: Reply
- 01:4101:41, 21 August 2022 diff hist +933 Talk:Cassava Sciences →No products approved by the FDA: Reply Tag: Reply
- 01:3201:32, 21 August 2022 diff hist +2,269 Talk:Cassava Sciences →Clinical data updates with press references: Reply Tag: Reply
19 August 2022
- 19:4919:49, 19 August 2022 diff hist +346 Talk:Cassava Sciences →Intro needs help: Reply Tag: Reply
- 19:4619:46, 19 August 2022 diff hist +1,388 Talk:Cassava Sciences →Intro needs help: Reply Tag: Reply
